Dinah Foer

1.3k total citations
45 papers, 654 citations indexed

About

Dinah Foer is a scholar working on Physiology, Pulmonary and Respiratory Medicine and General Health Professions. According to data from OpenAlex, Dinah Foer has authored 45 papers receiving a total of 654 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Physiology, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in General Health Professions. Recurrent topics in Dinah Foer's work include Asthma and respiratory diseases (16 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers) and Diabetes Treatment and Management (5 papers). Dinah Foer is often cited by papers focused on Asthma and respiratory diseases (16 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers) and Diabetes Treatment and Management (5 papers). Dinah Foer collaborates with scholars based in United States, Switzerland and Austria. Dinah Foer's co-authors include David W. Bates, Katherine N. Cahill, Elizabeth W. Karlson, Jing Cui, Kathleen M. Buchheit, Joshua A. Boyce, Liqin Wang, Li Zhou, Patrick E. Beeler and Theresa Soriano and has published in prestigious journals such as The Journal of Immunology, American Journal of Respiratory and Critical Care Medicine and Journal of Allergy and Clinical Immunology.

In The Last Decade

Dinah Foer

40 papers receiving 641 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dinah Foer United States 13 167 115 98 83 83 45 654
Rahul Potluri United Kingdom 18 109 0.7× 121 1.1× 104 1.1× 119 1.4× 92 1.1× 59 1.1k
Steve Chaplin United Kingdom 11 55 0.3× 51 0.4× 47 0.5× 83 1.0× 77 0.9× 230 804
Jonathan H. Watanabe United States 16 53 0.3× 37 0.3× 90 0.9× 37 0.4× 73 0.9× 63 973
G. Duru France 16 386 2.3× 248 2.2× 64 0.7× 55 0.7× 49 0.6× 43 1.3k
Aurore Palmaro France 17 46 0.3× 110 1.0× 57 0.6× 52 0.6× 43 0.5× 42 1.2k
Shinya Kimura Japan 13 58 0.3× 68 0.6× 38 0.4× 43 0.5× 100 1.2× 22 781
Jaap E. Tulleken Netherlands 22 64 0.4× 111 1.0× 83 0.8× 162 2.0× 204 2.5× 62 1.2k
Helady Sanders‐Pinheiro Brazil 19 75 0.4× 118 1.0× 67 0.7× 146 1.8× 40 0.5× 73 950
Emily S. Lau United States 22 111 0.7× 104 0.9× 43 0.4× 110 1.3× 165 2.0× 81 1.4k
Subodh J. Saggi United States 16 105 0.6× 157 1.4× 62 0.6× 337 4.1× 37 0.4× 32 1.1k

Countries citing papers authored by Dinah Foer

Since Specialization
Citations

This map shows the geographic impact of Dinah Foer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dinah Foer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dinah Foer more than expected).

Fields of papers citing papers by Dinah Foer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dinah Foer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dinah Foer. The network helps show where Dinah Foer may publish in the future.

Co-authorship network of co-authors of Dinah Foer

This figure shows the co-authorship network connecting the top 25 collaborators of Dinah Foer. A scholar is included among the top collaborators of Dinah Foer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dinah Foer. Dinah Foer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Foer, Dinah, et al.. (2025). Asthma Biologics Utilization in Patients With Obesity. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A5259–A5259.
2.
Yang, Richard, et al.. (2025). Management of Patients With Comorbid Asthma and Obesity: A Large Language Model Evaluation of Clinical Documentation. The Journal of Allergy and Clinical Immunology In Practice. 14(1). 138–150.e6.
3.
McDowell, Alex, Vicki Fung, David W. Bates, & Dinah Foer. (2024). Factors Associated with Completeness of Sex and Gender Fields in Electronic Health Records. LGBT Health. 12(3). 212–219.
4.
Foer, Dinah, Taneem Amin, Jun Nagai, et al.. (2023). Glucagon-like Peptide-1 Receptor Pathway Attenuates Platelet Activation in Aspirin-Exacerbated Respiratory Disease. The Journal of Immunology. 211(12). 1806–1813. 8 indexed citations
5.
Rudin, Robert S., Jessica Sousa, Jorge A. Rodriguez, et al.. (2023). Assessing Equitable Recruitment in a Digital Health Trial for Asthma. Applied Clinical Informatics. 14(4). 620–631. 7 indexed citations
6.
Hua, Yining, Liqin Wang, Alex McDowell, et al.. (2023). A deep learning approach for transgender and gender diverse patient identification in electronic health records. Journal of Biomedical Informatics. 147. 104507–104507. 3 indexed citations
7.
Foer, Dinah, Zachary H. Strasser, Jing Cui, et al.. (2023). Association of GLP-1 Receptor Agonists with Chronic Obstructive Pulmonary Disease Exacerbations among Patients with Type 2 Diabetes. American Journal of Respiratory and Critical Care Medicine. 208(10). 1088–1100. 29 indexed citations
8.
Akenroye, Ayobami, Jodi B Segal, Guohai Zhou, et al.. (2023). Comparative effectiveness of omalizumab, mepolizumab, and dupilumab in asthma: A target trial emulation. Journal of Allergy and Clinical Immunology. 151(5). 1269–1276. 36 indexed citations
9.
Dai, Ran, Yeongjin Gwon, Stephen I. Rennard, et al.. (2022). Identifying Individual Medications Affecting Pulmonary Outcomes When Multiple Medications are Present. Clinical Epidemiology. Volume 14. 731–735.
10.
Foer, Dinah, Matthew Wien, Elizabeth W. Karlson, et al.. (2022). Patient Characteristics Associated With Reactions to Mrgprx2-Activating Drugs in an Electronic Health Record–Linked Biobank. The Journal of Allergy and Clinical Immunology In Practice. 11(2). 492–499.e2. 12 indexed citations
11.
Wang, Liqin, et al.. (2021). PASCLex: A comprehensive post-acute sequelae of COVID-19 (PASC) symptom lexicon derived from electronic health record clinical notes. Journal of Biomedical Informatics. 125. 103951–103951. 36 indexed citations
12.
Baek, Seung Han, Dinah Foer, Katherine N. Cahill, et al.. (2021). Systems Approaches to Treatment Response to Imatinib in Severe Asthma: A Pilot Study. Journal of Personalized Medicine. 11(4). 240–240. 5 indexed citations
13.
Sanchez, David A., et al.. (2021). Evaluation of Allergic Diseases in Transgender and Gender-Diverse Patients: A Case Study of Asthma. The Journal of Allergy and Clinical Immunology In Practice. 10(1). 352–354. 3 indexed citations
14.
Rudin, Robert S., Nabeel Qureshi, Dinah Foer, Anuj K. Dalal, & Maria Orlando Edelen. (2021). Toward an asthma patient-reported outcome measure for use in digital remote monitoring. Journal of Asthma. 59(8). 1697–1702. 2 indexed citations
15.
Foer, Dinah, Patrick E. Beeler, Jing Cui, et al.. (2020). Asthma Exacerbations in Patients with Type 2 Diabetes and Asthma on Glucagon-like Peptide-1 Receptor Agonists. American Journal of Respiratory and Critical Care Medicine. 203(7). 831–840. 91 indexed citations
16.
Foer, Dinah & Kathleen M. Buchheit. (2018). Presentation and natural history of progestogen hypersensitivity. Annals of Allergy Asthma & Immunology. 122(2). 156–159. 7 indexed citations
17.
Foer, Dinah, Meiling Zhu, Rebecca Cardone, et al.. (2017). Impact of gain-of-function mutations in the low-density lipoprotein receptor-related protein 5 (LRP5) on glucose and lipid homeostasis. Osteoporosis International. 28(6). 2011–2017. 9 indexed citations
18.
Foer, Dinah, et al.. (2016). Progestogen Hypersensitivity in 24 Cases: Diagnosis, Management, and Proposed Renaming and Classification. The Journal of Allergy and Clinical Immunology In Practice. 4(4). 723–729. 59 indexed citations
19.
Simpson, Christine, Dinah Foer, Jessica Bihuniak, et al.. (2014). Serum levels of sclerostin, Dickkopf-1, and secreted frizzled-related protein-4 are not changed in individuals with high bone mass causing mutations in LRP5. Osteoporosis International. 25(10). 2383–2388. 4 indexed citations
20.
Foer, Dinah, et al.. (2011). Nonmedical factors associated with prolonged hospital length of stay in an urban homebound population. Journal of Hospital Medicine. 7(2). 73–78. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rahul Potluri Breakdown of academic impact, for papers by Steve Chaplin Breakdown of academic impact, for papers by Jonathan H. Watanabe Breakdown of academic impact, for papers by G. Duru Breakdown of academic impact, for papers by Aurore Palmaro Breakdown of academic impact, for papers by Shinya Kimura Breakdown of academic impact, for papers by Jaap E. Tulleken Breakdown of academic impact, for papers by Helady Sanders‐Pinheiro Breakdown of academic impact, for papers by Emily S. Lau Breakdown of academic impact, for papers by Subodh J. Saggi
Rankless by CCL
2026